Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000234117 is annotated as an antisense transcript situated on the opposite strand of the BET3L gene, now officially named TRAPPC3L ("Trafficking protein particle complex subunit 3L"). TRAPPC3L is a protein involved in vesicular transport between the endoplasmic reticulum and Golgi apparatus and functions as a component of the TRAPP complex. The antisense transcript ENSG00000234117, however, is likely a long non-coding RNA (lncRNA) or pseudogene and does not encode a protein. There is little evidence for any direct biological function, therapeutic targeting, disease association, or use as biomarker for this transcript. It mostly reflects a genomic annotation with unclear physiological relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to Trafficking protein particle complex subunit 3L.